Ariskon Pharma Private Limited

Ariskon Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2007PTC161598 Incorporated 03 April 2007 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹57.57 Lakh
▲ 48% YoY
Net profit · FY 2024
₹48,000
Net margin 0.8%
EBITDA · FY 2024
₹9.17 Lakh
EBITDA margin 15.9%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹12.6 Lakh
Issued & subscribed
Open charges
₹49.01 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
8
Provident fund records

About Ariskon Pharma Private Limited

Data last updated:

Ariskon Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 April 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2007PTC161598. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹12.6 Lakh. It is led by directors Barun Kumar Singh and Dinesh Kumar Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 207 Harsha House Karampura Commercial Complex, New Delhi, Delhi, India – 110015.

As per the financials filed for FY 2024, the company reported a revenue of ₹57.57 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹48,000 (net margin 0.8%) and EBITDA of ₹9.17 Lakh (EBITDA margin 15.9%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 32% over five years.

The company has about 8 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹49.01 Lakh on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it.

Ariskon Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0017562). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232DL2007PTC161598
Registration Number 161598
Incorporation Date 03 April 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0017562
Key People
Barun Kumar Singh Director Dinesh Kumar Singh Director

Recognitions & Rankings of Ariskon Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-BR-26-0017562

Contact details

Ariskon Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    207 Harsha House Karampura Commercial Complex, New Delhi, Delhi, India – 110015
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ariskon Pharma Private Limited, buy the company report.

Comprehensive company report
Ariskon Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ariskon Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ariskon Pharma Private Limited, buy the company report.

Financials of Ariskon Pharma Private Limited

FY 2025 filings available

Ariskon Pharma Private Limited reported revenue of ₹57.57 Lakh (up 48% YoY) for FY 2024.

Revenue · FY 2024
₹57.57 Lakh ▲ 48%
Net profit · FY 2024
₹48,000 margin 0.8%
EBITDA · FY 2024
₹9.17 Lakh margin 15.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▼ 16%
5 years · compounded
▼ 32%
EBITDA CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 36%
5 years · compounded
▼ 4%

Revenue rose 48% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 32%. EBITDA rose 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.17 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹48,000
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin15.9%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ariskon Pharma Private Limited, buy the company report.

Board of directors of Ariskon Pharma Private Limited

Ariskon Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Barun Kumar Singh
Also directs: Noksira Pharma Private Limited
Director03 Apr 200719 Years 7 MonthsCurrent
Dinesh Kumar Singh
Also directs: Noksira Pharma Private Limited, JC Lifecare Private Limited
Director03 Apr 200719 Years 7 MonthsCurrent
View all directors

Peer comparison

Ariskon Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Radius Drug Private Limited₹57.77 Lakh (FY 2025)91.0%Csa, Uttar Pradesh, India
Zatix Pharmaceuticals Private Limited₹57.7 Lakh (FY 2024)46.0%New Delhi, Delhi, India
Beyondinfinite.Com Semiconductor Private Limited₹57.59 Lakh (FY 2024)61.0%New Delhi, Delhi, India
Ariskon Pharma Private Limitedthis company₹57.57 Lakh (FY 2024)₹48,0000.8%48.0%8New Delhi, Delhi, India
Beeok Healthcare Private Limited₹57.42 Lakh (FY 2024)63.0%Bangalore, Karnataka, India
Navalor Healthcare Private Limited₹57.23 Lakh (FY 2023)-23.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Ariskon Pharma Private Limited, buy the company report.

Shareholding

The shareholding of Ariskon Pharma Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ariskon Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹49.01 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.46 Cr
Union Bank of India₹0.03 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Jan 2023100686526Others₹6.01 LakhOpen
30 May 2020100345717Others₹40 LakhOpen
05 Dec 201110326310Union Bank of India₹3 LakhOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ariskon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Ariskon Pharma Private Limited has a workforce of 8 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.

Employee count
8
Active EPFO establishments
1
Employee growth
-65.22%

GST

Ariskon Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Ariskon Pharma Private Limited, buy the company report.

Recent activity

Ariskon Pharma Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Rana Amrendra Kumar Deepak ceased to be Director on 30 Nov 2016.

AGM
Ariskon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ariskon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 6.01 Lakh with Charge ID 100686526 was registered on 07 Jan 2023.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100345717 was registered on 30 May 2020.
Ceased
Rana Amrendra Kumar Deepak ceased to be Director.
Charges
A charge with Union Bank Of India amounted to Rs. 3.00 Lakh with Charge ID 10326310 was registered on 05 Dec 2011.
Appointed
Barun Kumar Singh was appointed as Director.
Appointed
Dinesh Kumar Singh was appointed as Director.
Incorporation
03 Apr 2007
Ariskon Pharma Private Limited was registered on 03 Apr 2007 with Roc Delhi Ii & aged 19 years 7 months as per MCA records.

Frequently asked questions

Ariskon Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 April 2007 (19+ years old) and is registered under CIN U24232DL2007PTC161598.

Ariskon Pharma has 2 current directors:

The latest financial statements of Ariskon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Ariskon Pharma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Ariskon Pharma is U24232DL2007PTC161598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ariskon Pharma has 7 court cases on record: 1 filed by the company and 6 filed against it. Most are in the district courts.

Ariskon Pharma was incorporated on 03 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ariskon Pharma by revenue are Radius Drug Private Limited, Zatix Pharmaceuticals Private Limited, Beyondinfinite.Com Semiconductor Private Limited, Beeok Healthcare Private Limited, Navalor Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Rana Amrendra Kumar Deepak ceased to be Director on 30 Nov 2016. Barun Kumar Singh was appointed as Director on 03 Apr 2007. Dinesh Kumar Singh was appointed as Director on 03 Apr 2007.

Yes, Ariskon Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0017562).

The registered office of Ariskon Pharma is at 207 Harsha House Karampura Commercial Complex, New Delhi, Delhi, India – 110015.